Interesting research:

Our data strongly support the notion that glucose metabolism, and G-6P transporter UhpC in particular, is targeted by KSK120. This agrees with previous data that suggest that G-6P metabolic processes are critical for Chlamydia infectivity. Thus, KSK120 may prove useful for studying glucose metabolism in Chlamydia spp., and its analogs may also be useful in other intracellulari bacteria. Importantly, host G-6P is available only to intracellular bacteria and not to those that reside extracellularly. Thus, KSK120 may represent a new class of drugs that can specifically treat infectionsi of intracellular bacterial pathogens such as Chlamydia while leaving the normal bacterial flora unperturbed.


chlamydophila cell inclusion ksk120

I'm pretty dull right now but this does look interesting. Thank you.


PPMSi-misdiagnosed 2001-diagnosed 2006. Probably caught cpni in birth canal but it didn't pass BBBi until my 40s. Minocycline 7 mos.- resulting bronchitis 5 months.Go to private m.d. out-of-plan. Wheldon CAPi 3/2/07 Stopped 12/12; resumed 12/13

Comment viewing options

Select your preferred way to display the comments and click "Save settings" to activate your changes.